KLH-conjugated pentavalent cancer vaccine (GD2L, GD3L, Globo H, Fucosyl GM1, and N-propionylated polysialic acid)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KLH-conjugated pentavalent cancer vaccine (GD2L, GD3L, Globo H, Fucosyl GM1, and N-propionylated polysialic acid), covering 2016-01-05 to 2016-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid [Phase 1]